nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Combination therapy for relapsed peripheral T-cell lymphoma: is two better than one?
|
Bachy, Emmanuel |
|
2015 |
2 |
8 |
p. e307-e308 nvt p. |
artikel |
2 |
Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomised, multicentre, placebo-controlled study
|
Bussel, James B |
|
2015 |
2 |
8 |
p. e315-e325 nvt p. |
artikel |
3 |
ISTH 2015 Congress
|
Smith, Lan-Lan |
|
2015 |
2 |
8 |
p. e313-e314 nvt p. |
artikel |
4 |
Lymphoma: that's classified
|
The Lancet Haematology, |
|
2015 |
2 |
8 |
p. e306- 1 p. |
artikel |
5 |
Palliation for haematological and solid tumours: what difference?
|
Noble, Simon |
|
2015 |
2 |
8 |
p. e309-e310 nvt p. |
artikel |
6 |
Panobinostat in combination with bortezomib in patients with relapsed or refractory peripheral T-cell lymphoma: an open-label, multicentre phase 2 trial
|
Tan, Daryl |
|
2015 |
2 |
8 |
p. e326-e333 nvt p. |
artikel |
7 |
Symptom burden of haematological malignancies as death approaches in a community palliative care service: a retrospective cohort study of a consecutive case series
|
LeBlanc, Thomas W |
|
2015 |
2 |
8 |
p. e334-e338 nvt p. |
artikel |
8 |
Targeting Hedgehog in haematological malignancies
|
Ghia, Paolo |
|
2015 |
2 |
8 |
p. e311-e312 nvt p. |
artikel |
9 |
Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: a phase 1 safety and pharmacokinetics study
|
Martinelli, Giovanni |
|
2015 |
2 |
8 |
p. e339-e346 nvt p. |
artikel |